MHC Stock Overview
Develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
MyHealthChecked PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.10 |
| 52 Week High | UK£0.17 |
| 52 Week Low | UK£0.083 |
| Beta | 1.35 |
| 11 Month Change | -9.89% |
| 3 Month Change | -16.33% |
| 1 Year Change | -38.81% |
| 33 Year Change | -80.19% |
| 5 Year Change | -75.60% |
| Change since IPO | -93.79% |
Recent News & Updates
Recent updates
Market Still Lacking Some Conviction On MyHealthChecked PLC (LON:MHC)
Jun 11
There's Been No Shortage Of Growth Recently For MyHealthChecked's (LON:MHC) Returns On Capital
Dec 29Returns Are Gaining Momentum At MyHealthChecked (LON:MHC)
Sep 20MyHealthChecked (LON:MHC) Could Become A Multi-Bagger
May 12MyHealthChecked (LON:MHC) Is Investing Its Capital With Increasing Efficiency
Jan 06We Think MyHealthChecked's (LON:MHC) Profit Is Only A Baseline For What They Can Achieve
Jun 14Shareholder Returns
| MHC | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.9% | 1.1% |
| 1Y | -38.8% | -11.0% | 8.1% |
Return vs Industry: MHC underperformed the UK Medical Equipment industry which returned -11% over the past year.
Return vs Market: MHC underperformed the UK Market which returned 8.1% over the past year.
Price Volatility
| MHC volatility | |
|---|---|
| MHC Average Weekly Movement | 9.5% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: MHC has not had significant price volatility in the past 3 months.
Volatility Over Time: MHC's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 16 | Penny McCormick | myhealthchecked.com |
MyHealthChecked PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. It offers general health and energy profile blood test, bowel health rapid test, and stomach ulcer rapid test; nutritional health tests, such as intolerances and sensitivities DNA tests, vitamins and minerals DNA and profile blood tests, iron deficiency rapid test, and vitamin D rapid test; and weight management tests, that includes weight management DNA and blood tests, glucose management DNA tests, thyroid profile blood test, and stimulating hormone rapid test. The company also provides cardiovascular health tests, such as heart profile blood and DNA test; menopause profile blood test; polycystic ovarian syndrome blood test; female sexual health test; erectile dysfunction blood test; sperm concentration rapid test; and male sexual health test.
MyHealthChecked PLC Fundamentals Summary
| MHC fundamental statistics | |
|---|---|
| Market cap | UK£5.33m |
| Earnings (TTM) | -UK£159.00k |
| Revenue (TTM) | UK£10.98m |
0.5x
P/S Ratio-33.5x
P/E RatioIs MHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MHC income statement (TTM) | |
|---|---|
| Revenue | UK£10.98m |
| Cost of Revenue | UK£8.93m |
| Gross Profit | UK£2.05m |
| Other Expenses | UK£2.21m |
| Earnings | -UK£159.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0031 |
| Gross Margin | 18.66% |
| Net Profit Margin | -1.45% |
| Debt/Equity Ratio | 0% |
How did MHC perform over the long term?
See historical performance and comparison